Heron Therapeutics Inc (NASDAQ:HRTX)

29.65
Delayed Data
As of Jun 18
 -0.30 / -1.00%
Today’s Change
12.70
Today|||52-Week Range
35.40
+63.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues8.5M8.6M10.1M11.6M
 
 
 
 
 
Cost of Goods Sold601.0K646.0K953.0K2.8M
 
 
 
 
 
Depreciation And Amortization412.0K405.0K385.0K381.0K
 
 
 
 
 
 
Operating ExpensesGross Income7.5M7.5M8.7M8.4M
 
 
 
 
 
General Expenses49.0M48.6M70.7M59.9M
 
 
 
 
 
Research And Development28.0M28.6M47.9M39.6M
 
 
 
 
 
Total Operating Expenses50.0M49.7M72.0M63.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-41.5M-41.1M-62.0M-51.5M
 
 
 
 
 
Extraordinary Credit0.000.00100.0K0.00
 
 
Extraordinary Charge-600.0K-200.0K0.00-500.0K
 
 
 
 
Interest Expense On Debt744.0K552.0K600.0K275.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-42.8M-41.9M-62.5M-52.3M
 
 
 
 
 
Net Income-42.8M-41.9M-62.5M-52.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS53.8M54.2M57.6M64.7M
 
 
 
 
 
Shares To Calculate EPS Diluted53.8M54.2M57.6M64.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.80-$0.77-$1.09-$0.81
 
 
 
 
 
EPS Diluted-$0.80-$0.77-$1.09-$0.81